US Nuclear (UCLE) AI Stock Analysis

• Market Cap: $3.60M
• Dividend Yield: N/A
• Average Volume (3M): 281.28K
• Price to Earnings (P/E): ―
• Beta (1Y): -16.23
• Revenue Growth: -16.18%
• EPS Growth: 35.81%
• Country: US
• Employees: 8
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): N/A
• Shares Outstanding: 60,077,263
• 10 Day Avg. Volume: 117,656
• 30 Day Avg. Volume: 281,279
• PEG Ratio: 0.04
• Price to Book (P/B): -4.31
• Price to Sales (P/S): 1.69
• P/FCF Ratio: -7.26
• Enterprise Value/Market Cap: 0.72
• Enterprise Value/Revenue: 1.31
• Enterprise Value/Gross Profit: 2.60
• Enterprise Value/Ebitda: -1.51
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 53 Neutral
• Price Target: $0.13 ▼(-0.77% Downside)

US Nuclear's stock score is primarily impacted by its poor financial performance, characterized by ongoing losses and high leverage. While technical analysis shows positive short-term momentum, the negative P/E ratio and lack of dividend yield highlight valuation concerns. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Innovative Product Offering

The company's focus on advanced radiation detection technologies positions it well in the nuclear safety market, offering durable growth potential.

Strategic Partnerships

Collaborations with government and educational bodies provide stable funding for R&D, supporting long-term innovation and market relevance.

Proprietary Technology

Licensing proprietary technologies can create recurring revenue streams, enhancing financial stability and competitive edge over time.

Negative Factors

High Financial Leverage

High leverage increases financial risk, limiting flexibility and potentially impacting the company's ability to invest in growth opportunities.

Negative Cash Flow

Negative cash flow indicates operational challenges, potentially hindering the company's ability to sustain operations without external financing.

Inconsistent Revenue Growth

Inconsistent revenue growth reflects market challenges and may affect long-term profitability and market positioning.

US Nuclear Business Overview & Revenue Model

Company Description

US Nuclear Corporation (UCLE) is a leading provider of radiation detection and monitoring systems, specializing in advanced technologies for nuclear safety and environmental monitoring. The company operates primarily in the nuclear industry, offering a range of products and services that include radiation detection equipment, radiation monitoring systems, and environmental assessment solutions. UCLE focuses on innovations that enhance the safety and efficiency of nuclear operations, catering to both government and commercial sectors.

How the Company Makes Money

US Nuclear generates revenue through the sale of its radiation detection and monitoring products, which are essential for ensuring safety in nuclear facilities and other industries that require radiation monitoring. Key revenue streams include direct sales of specialized equipment, ongoing maintenance and support services, and potential licensing agreements for its proprietary technologies. The company also benefits from partnerships with governmental agencies and educational institutions, which provide funding for research and development projects, further contributing to its financial growth.

US Nuclear Financial Statement Overview

Summary

US Nuclear is struggling financially, with ongoing losses and high leverage. Negative equity and cash flow issues present significant risks. Revenue growth is inconsistent, and profitability remains a challenge. The company needs to address these issues to stabilize and improve its financial health.

Income Statement

The company has consistently reported negative net income, indicating ongoing losses. The gross profit margin is moderate but insufficient to cover operating expenses, leading to negative EBIT and EBITDA margins. Revenue growth has been inconsistent, showing a decline in recent years.

Balance Sheet

The balance sheet reveals a concerning financial structure with negative stockholders' equity, indicating liabilities exceed assets. The debt-to-equity ratio is effectively infinite due to negative equity, highlighting high financial leverage and potential risk. The equity ratio is negative, further emphasizing financial instability.

Cash Flow

The cash flow statement shows persistent negative free cash flow, indicating cash outflows exceed inflows. The operating cash flow to net income ratio is negative, reflecting cash flow challenges. Financing activities have been the main source of cash, but this is unsustainable in the long term.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.98M	2.19M	2.23M	2.09M	2.14M	1.75M
Gross Profit	1.00M	1.02M	924.31K	788.07K	1.38M	474.51K
EBITDA	-1.73M	-1.51M	-1.78M	-1.49M	-1.81M	-2.87M
Net Income	-1.89M	-1.74M	-3.43M	-2.04M	-1.88M	-3.54M
Balance Sheet
Total Assets	2.51M	2.65M	2.86M	3.11M	2.85M	2.45M
Cash, Cash Equivalents and Short-Term Investments	46.28K	130.84K	152.84K	126.11K	246.32K	227.30K
Total Debt	1.37M	1.78M	2.24M	1.60M	910.27K	825.48K
Total Liabilities	805.27K	3.50M	4.84M	3.46M	2.41M	1.61M
Stockholders Equity	-750.70K	-856.16K	-1.98M	-348.30K	441.27K	847.16K
Cash Flow
Free Cash Flow	-566.13K	-509.05K	-264.30K	-1.32M	-447.47K	-614.15K
Operating Cash Flow	-566.13K	-509.05K	-263.44K	-1.32M	-441.03K	-614.15K
Investing Cash Flow	-12.69K	-30.77K	-24.55K	0.00	-21.45K	-235.00K
Financing Cash Flow	487.26K	517.82K	314.72K	1.20M	481.49K	-11.21K

US Nuclear Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.13
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UCLE, the sentiment is Negative. The current price of 0.13 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.08, and above the 200-day MA of 0.05, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.91 is Neutral, neither overbought nor oversold. The STOCH value of 40.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UCLE.

US Nuclear Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LGL	64 Neutral	$31.92M	35.27	2.33%	―	14.07%	153.24%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
MIND	60 Neutral	$83.42M	24.06	9.37%	―	2.21%	-15.60%
CPSH	60 Neutral	$57.71M	-79.06	-3.84%	―	38.22%	70.68%
UCLE	53 Neutral	$3.60M	-1.45	―	―	-16.18%	35.81%
NEON	49 Neutral	$32.39M	3.61	38.72%	―	-48.54%	―

US Nuclear Corporate Events

US Nuclear Corp. Delays Q3 10-Q Filing

US Nuclear Corp. has filed a Form 12b-25, notifying a delay in its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The delay is primarily due to the need for additional time to compile and analyze supporting documentation, as well as to allow the company’s independent accounting firm to complete its review of the consolidated financial statements. The company anticipates filing the Form 10-Q within five calendar days following the prescribed due date. There are no expected significant changes in financial results from the previous fiscal period. US Nuclear Corp. is actively working to ensure compliance, with CEO Robert Goldstein signing off on the notification.